iSpecimen IncISPC
Price$1.18

Financial Snapshot

Revenue, profitability, returns, debt, and capital allocation

Revenue $1.9M-79.2% YoYTTM through 31 Dec 2025
Net Income -$10.5MTTM through 31 Dec 2025
Free Cash Flow -$4.2MTTM through 31 Dec 2025

Margins

Current
Gross Margin1.0%
Operating Margin-465.3%
Net Margin-543.5%

Returns

-339.7%ROE
-110.1%ROA

Balance Sheet Health

Debt / Equity0.00x
Current Ratio1.10x
Net Debt-$6.9Mnet cash position
Cash & Equivalents$6.9M

Quality Metrics

FCF Margin-219.7%
Earnings-Beat Rate50.0%

Dividend

No dividend

Segment Performance

SegmentRevenueYoYOutlook
Human Biospecimen Marketplace$1.9M-79.2%
View details

The company is focused on platform modernization, cost reductions, and expanding its healthcare provider network to stabilize operations.

All values are periodic snapshots, not live quotes. Source dates are shown for reference.

Filing Detail Members

This section is available to registered members. Create a free account or sign in to unlock the full breakdown.

Sign in / Sign up
AI-assisted, source-linked narrative; figures from company filings (SEC EDGAR) and market data. Dates shown per section. Not investment advice. Terms of Use.